Modified Estrogen-Progesterone Induction Method of Mammary Gland Hyperplasia in Rats

Bull Exp Biol Med. 2023 May;175(1):112-115. doi: 10.1007/s10517-023-05821-2. Epub 2023 Jun 19.

Abstract

In female Wistar rats, mammary gland hyperplasia (MGH) was modeled according to a modified protocol involving estrogen-progesterone induction and taking into account the duration of the estrous cycle of this animal species. MGH was induced over four 7-day cycles; each cycle included subcutaneous administration of 17β-estradiol (0.5 mg/kg) for 4 days, injection of progesterone (5 mg/kg) on day 5, then 2 days without injections. In females with MGH, a significant increase in the height and diameter of the nipples of the mammary glands was recorded, two types of changes were observed in the gland tissue: tubuloalveolar and lobuloalveolar hyperplasia. The study confirmed the development of MGH in rats by a modified method.

Keywords: breast; hormones; hyperplasia; mammary gland hyperplasia; model.

MeSH terms

  • Animals
  • Estradiol / pharmacology
  • Estrogens* / pharmacology
  • Female
  • Hyperplasia / chemically induced
  • Hyperplasia / pathology
  • Mammary Glands, Animal / pathology
  • Progesterone* / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Progesterone
  • Estrogens
  • Estradiol